Literature DB >> 20207722

Tissue Doppler echocardiography reveals distinct patterns of impaired myocardial velocities in different degrees of coronary artery disease.

Soren Hoffmann1, Rasmus Mogelvang, Niels Thue Olsen, Peter Sogaard, Thomas Fritz-Hansen, Jan Bech, Soren Galatius, Jan Kyst Madsen, Jan Skov Jensen.   

Abstract

UNLABELLED: Aim To determine how the left ventricular wall motion assessed by echocardiographic Tissue Doppler Imaging (TDI) is affected by increasing severity of coronary artery disease (CAD) among patients with stable angina pectoris and preserved ejection fraction. METHODS AND
RESULTS: This study comprises 82 patients with suspected angina pectoris, no previous cardiac history, and a normal ejection fraction, who were all examined with colour TDI prior to coronary angiography. Patients without significant stenoses (n = 35) constituted the control group and patients with significant stenoses (n = 47) were divided into three groups according to significant one-, two-, or three-vessel disease (n = 18, n = 14, and n = 15, respectively). Regional longitudinal peak systolic (s'), early (e'), and late diastolic (a') myocardial velocities were measured at six mitral annular sites and averaged to provide global estimates. Each patient with significant coronary disease was matched with a control of the same age, sex, body mass index, and status regarding diabetes and hypertension. Global systolic and diastolic performance by TDI (in terms of global s' and E/e') were negatively correlated to the number of vessels with significant stenoses (both P < 0.05). Regional analyses revealed that in one- and two-vessel disease, e' decreased significantly in the segments supplied by a stenotic artery. In patients with one-vessel disease, a' increased compensatorily with a significant reduction of e'/a'-ratio (0.86 +/- 0.24 vs. 1.00 +/- 0.28, P < 0.05). Both regional and global s' was significantly reduced in patients with three-vessels disease.
CONCLUSION: Colour TDI performed at rest in patients with stable angina and preserved ejection fraction reveals both diastolic and systolic dysfunction and the nature of the dysfunction depends on the extent of the CAD.

Entities:  

Mesh:

Year:  2010        PMID: 20207722     DOI: 10.1093/ejechocard/jeq015

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  5 in total

1.  Letter by Garcia A, et al. regarding article: Coronary artery disease risk reclassification by a new acoustic-based score.

Authors:  Artemio García-Escobar; Alfonso Martín-Martínez; Jorge Del-Toro-Cervera; Pablo Demelo-Rodríguez
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-26       Impact factor: 2.357

2.  Left atrial enlargement and reduced physical function during aging.

Authors:  Andrew A Pellett; Leann Myers; Michael Welsch; S Michal Jazwinski; David A Welsh
Journal:  J Aging Phys Act       Date:  2012-12-10       Impact factor: 1.961

3.  Evaluation of Coronary Artery Disease Using Myocardial Elastography with Diverging Wave Imaging: Validation against Myocardial Perfusion Imaging and Coronary Angiography.

Authors:  Julien Grondin; Marc Waase; Alok Gambhir; Ethan Bunting; Vincent Sayseng; Elisa E Konofagou
Journal:  Ultrasound Med Biol       Date:  2017-02-28       Impact factor: 2.998

4.  Echocardiographic markers of inducible myocardial ischemia at baseline evaluation preparatory to exercise stress echocardiography.

Authors:  Antonella Cherubini; Giovanni Cioffi; Carmine Mazzone; Giorgio Faganello; Giulia Barbati; Luigi Tarantini; Giulia Russo; Carlo Stefenelli; Franco Humar; Eliana Grande; Maurizio Fisicaro; Claudio Pandullo; Andrea Di Lenarda
Journal:  Cardiovasc Ultrasound       Date:  2016-06-01       Impact factor: 2.062

Review 5.  Tissue Doppler imaging for diagnosis of coronary artery disease: a systematic review and meta-analysis.

Authors:  Rajender Agarwal; Priyanka Gosain; James N Kirkpatrick; Tareq Alyousef; Rami Doukky; Gurpreet Singh; Craig A Umscheid
Journal:  Cardiovasc Ultrasound       Date:  2012-11-30       Impact factor: 2.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.